Synergy Pharma (SGYP) to Exchange $20.7M in Notes Into 7.56M Common Shares

November 22, 2016 9:28 AM EST

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Synergy Pharma (NASDAQ: SGYP) is modestly lower in pre-open trade (-2.3%) after the company disclosed it enered into separate, privately-negotiated exchange agreements with certain holders of the Company’s 7.50% Convertible Senior Notes due 2019. Under the exchange agreements, the Holders agreed to exchange an aggregate principal amount of approximately $20.7 million of Notes and accrued but unpaid interest under the Notes held by them in exchange for 7,555,683 shares of the Company’s common stock, par value $0.0001 per share.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Equity Offerings, Trader Talk

Related Entities

Pre Market Movers

Add Your Comment